verified SJR 0,769 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Current Science, Inc.

workspace_premium Q2 — Infectious Diseases lock_open Open Access

Current Infectious Disease Reports

Current Infectious Disease Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal...

ISSN: 1523-3847

Publisher: Current Science, Inc.

Category: Infectious Diseases

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Visit publisher site menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,769 Q2

H-index 63

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.060 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,769

H-index

Docs (year)

Docs 3y

Total refs

1484

Cites 3y

242

Citable 3y

Cites/Doc 2y

2.86

Ref/Doc

61.83

Immediate OA

3060 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Benefits and Risks of Statin Therapy in the HIV-Infected Population

When to Start Antiretroviral Therapy

Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection

Current place of vasopressin analogues in the treatment of septic shock

Comprehensive Approaches to the Diagnosis and Treatment of HIV Infection in the Community: Can "Seek and Treat" Really Deliver?

Combination antifungal therapy: From bench to bedside

Clinical trials report

Clinical Trial Report: Viral Coinfections with Invasive Pneumococcal Disease

Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Na?Øve, HIV-1-Infected Patients

Changing epidemiology of bacterial meningitis in the United States

Cervicitis of Unknown Etiology

SHOW MORE ARTICLES

Cardiovascular complications in patients with HIV infection

A tuberculosis treatment completion trial

Azole Antifungal Resistance Today: Focus on Aspergillus

Azithromycin versus penicillin in acute group A streptococcal tonsillopharyngitis

Anxiety on the watchtower: The hospital epidemiologist and emerging infectious diseases

Antiretroviral Treatment and Resistance Patterns in HIV-Infected Children

Antiretroviral therapy: When to start and which drugs to use

Antibiotics for travelers: What's good and what's not

Aiming for zero: Is complete elimination of catheter-related bloodstream infections among intensive care unit patients a realistic goal?

African trypanosomiasis: Changing epidemiology and consequences

Advances in Diagnosis and Treatment of Interstitial Cystitis/Painful Bladder Syndrome

advances in diagnosing vaginitis: Development of a new algorithm

FAQs

Current Infectious Disease Reports has an SJR of 0,769 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 3060 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current Infectious Disease Reports is 30%.

Current Infectious Disease Reports

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Infectious Disease Reports?

What is the APC / publication cost?

What is the acceptance rate?